JPRN-UMIN000015224已完成未知
Studies to examine the best tumor reduction rate for predicting the pCR after two cycles docetaxel chemotherapy breast preoperative - Studies to examine the best tumor reduction rate for predicting the pCR after two cycles docetaxel chemotherapy breast preoperative
agasaki University Hospital0 个研究点目标入组 60 人开始时间: 2014年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 71years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Patient with suspected infection has a fever or a patient, has been complicated by infection. 2. Patients with drug allergies severe. 3. Renal failure severe, patients with (jaundice) liver failure. 4. Patients with pulmonary fibrosis or interstitial pneumonia evident in chest X-ray. 5. Enhanced MRI of patients contraindicated 6. Patients with hypertension, diabetes uncontrolled.
研究者
相似试验
已完成
2 期
An investigation of antitumor effectiveness using M-VAC/CaG prediction system in neoadjuvant chemotherapy for muscle invasive bladder cancer.Muscle-invasive bladder cancerJPRN-UMIN000019902Department of Urology, Iwate Medical University35
尚未招募
1 期
Clinical study on reducing the malignant risk of residual lung GGN with Jiawei Xiaolong pill based on AI image judgment TechnologyGround glass nodule of lungITMCTR2000003831onghua Hospital Shanghai University of Traditional Chinese Medicine
进行中（未招募）
2 期
A randomised pilot study to investigate the optimum timing of gemcitabine and concurrent radiation therapy after induction gemcitabine and carboplatin for locally advanced non-small cell lung cancerAdvanced non-small cell lung cancerCancer - Lung - Non small cellACTRN12605000169640Princess Alexandra Hospital24
进行中（未招募）
1 期
Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis - TACITMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid ArthritisEUCTR2007-001190-28-GBKing's College London190
已完成
Unknown
A clinical trial in patients with malignancies where the spaces formed by the KHKA-01 are needed in performing particle radiation therapy.JPRN-jRCT1092220318Alfresa Pharma Corporation5